Watch Demo

Greece Anti-Infective Industry Outlook 2022 - 2026

See how Greece Anti-Infective performed compared to key markets such as the United Kingdom, Germany and South Korea.

Key Market Indicators

Sales of anti-infective medicines in Greece are expected to reach nearly $905 million by 2026, up from $881 million in 2021. This is an average growth rate of 0.8% year-on-year. Since 1995, the Greek market has grown by 4.7% year-on-year. In 2021, Australia overtook Greece as the leading market, with sales of $881 million. Germany, South Korea and Italy followed in second, third and fourth place respectively. Imports of antibiotics in Greece are forecast to reach $298 million by 2026, up from $242 million in 2021. This is an average growth rate of 3.5% year-on-year. Since 1993, Greek demand for antibiotics has grown by 29.7% year-on-year. Exports of antibiotics from Greece are expected to reach $10.3 million by 2026, up from $7.9 million in 2021. This is an average growth rate of 4.4% year-on-year. Since 1993, Greek supply of antibiotics has grown by 126.3% year-on-year. In 2021, New Zealand overtook Greece as the leading exporter, with exports of $7.9 million. Switzerland, Italy and India followed in second, third and fourth place respectively.

Greece Anti-Infective Market Data and Forecasts

How much will Greece Anti-Infective Market grow to 2026?

Forecast: Antiinfective Medicine Sales in Greece
Forecast: Antiinfective Medicine Sales in Greece
Forecast: Antibacterial Medicine Sales in Greece
Forecast: Antiinfective Medicine Sales in Greece
Forecast: Antibacterial Medicine Use in Greece
More in Anti-Infective Industry for 2027

Improve your Knowledge with the latest Indicators and Trends